BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21577032)

  • 1. Marathon run under chemotherapy: is it possible?
    Bernhörster M; Rosenhagen A; Vogt L; Thiel C; Jäger E; Banzer W
    Onkologie; 2011; 34(5):259-61. PubMed ID: 21577032
    [No Abstract]   [Full Text] [Related]  

  • 2. Marathon running during chemotherapy: where are the limits?
    Dimeo FC
    Onkologie; 2011; 34(5):230. PubMed ID: 21577027
    [No Abstract]   [Full Text] [Related]  

  • 3. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
    Canellos GP; Duggan D; Johnson J; Niedzwiecki D
    J Clin Oncol; 2004 Apr; 22(8):1532-3. PubMed ID: 15084636
    [No Abstract]   [Full Text] [Related]  

  • 4. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M
    Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.
    Arakelyan N; Jais JP; Delwail V; Brière J; Moles-Moreau MP; Sénécal D; Berthou C; Desablens B; Colonna P; Andrieu JM;
    Cancer; 2010 Sep; 116(17):4054-62. PubMed ID: 20564152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy alone for early Hodgkin's lymphoma: an emerging option.
    Canellos GP
    J Clin Oncol; 2005 Jul; 23(21):4574-6. PubMed ID: 15837972
    [No Abstract]   [Full Text] [Related]  

  • 7. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease.
    Williamson PJ; de Berker D
    Br J Haematol; 2005 Mar; 128(5):582. PubMed ID: 15725077
    [No Abstract]   [Full Text] [Related]  

  • 8. Hodgkin's lymphoma--the great teacher.
    Connors JM
    N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
    [No Abstract]   [Full Text] [Related]  

  • 9. Greater curability in advanced Hodgkin's disease?
    Portlock CS
    Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
    [No Abstract]   [Full Text] [Related]  

  • 10. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
    Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
    Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABVD chemotherapy of Hodgkin's disease.
    Molnár Z; Schneider T; Várady E; Fleischmann T
    Neoplasma; 1997; 44(4):263-5. PubMed ID: 9473781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The practice of chemotherapy with the DeVita protocol].
    Gassmann W; Schmitz N; Löffler H
    Dtsch Med Wochenschr; 1982 Jul; 107(27):1063-9. PubMed ID: 6177488
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiation in early-stage Hodgkin lymphoma.
    Meyer RM
    Clin Adv Hematol Oncol; 2013 Mar; 11(3):162-89. PubMed ID: 23598983
    [No Abstract]   [Full Text] [Related]  

  • 14. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
    Andrieu JM; Colonna P
    J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hodgkin's disease and AIDS. Presentation of 5 cases].
    García Alfonso P; Flores Sañudo E; Carrión Galindo R; Jara Sánchez C; Cosín Ochaita J
    Rev Clin Esp; 1988 Apr; 182(6):314-6. PubMed ID: 2457232
    [No Abstract]   [Full Text] [Related]  

  • 16. Hodgkin's disease associated cholestasis in a man with thymoma.
    Opeskin K; Burke M; McCaffrey G; Nandurkar H
    Pathology; 2003 Aug; 35(4):349-51. PubMed ID: 12959773
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
    Lipton JH; Gospodarowicz M; Reingold S
    Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
    Feng Q; Zak D; Daya R
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):270-6. PubMed ID: 22706493
    [No Abstract]   [Full Text] [Related]  

  • 19. How can outcomes be improved for older patients with Hodgkin lymphoma?
    Evens AM; Hong F
    J Clin Oncol; 2013 Apr; 31(12):1502-5. PubMed ID: 23509323
    [No Abstract]   [Full Text] [Related]  

  • 20. Bilateral sudden hearing loss following ABVD protocol.
    Tazi I; Nafil H; Mahmal L
    J Cancer Res Ther; 2014; 10(1):212. PubMed ID: 24762521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.